Search Results - Nikolas Plevris

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis by Laura A. Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris, Spyros Siakavellas, Lauranne A.A.P. Derikx, Gareth-Rhys Jones, Charles W. Lees

    Published in Therapeutic Advances in Gastroenterology (2021-12-01)
    Get full text
    Article


  2. 2

    Health-related quality of life outcomes among vedolizumab-treated patients with inflammatory bowel disease in the UK and Ireland: a 52-week observational study (OCTAVO) by Gareth Parkes, Ayesha Akbar, Ian Beales, Martin Buckley, Tom Creed, Said Din, Nikolas Plevris, Niamh Hogan, Nicola Heggs, Simon Meadowcroft, Mike Wallington, Aileen Fraser

    Published in Journal of Patient-Reported Outcomes (2025-07-01)
    Get full text
    Article


  3. 3

    Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis by Beatriz Gros, Hannah Ross, Maureen Nwabueze, Nathan Constantine-Cooke, Lauranne A. A. P. Derikx, Mathew Lyons, Claire O’Hare, Colin Noble, Ian D. Arnott, Gareth-Rhys Jones, Charlie W. Lees, Nikolas Plevris

    Published in Therapeutic Advances in Gastroenterology (2024-07-01)
    Get full text
    Article


Search Tools: